Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MULTIPLE SCLEROSIS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00203086
What this trial is testing

Evaluate the Long Term Safety and Effectiveness of Novantrone Therapy Followed by Copaxone Treatment for Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 30
Early research (Phase 1)Temporarily pausedNCT06677710
What this trial is testing

IDP-023 g-NK Cells Plus Ocrelizumab in Patients With Progressive Multiple Sclerosis

Who this might be right for
Multiple SclerosisPrimary Progressive Multiple Sclerosis (PPMS)Secondary Progressive Multiple Sclerosis (SPMS)+8 more
Indapta Therapeutics, INC. 34
Post-approval studies (Phase 4)Study completedNCT02471560
What this trial is testing

Tecfidera and the Gut Microbiota

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Biogen 36
Post-approval studies (Phase 4)Study completedNCT00536120
What this trial is testing

The Effects of Tysabri Treatment on Vaccination Response and Lymphocyte Subsets in Subjects With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Biogen 60
Not applicableWithdrawnNCT03684369
What this trial is testing

Improving Mobility and Reducing Fatigue in People With Multiple Sclerosis by Electrical Stimulation Therapy

Who this might be right for
Multiple Sclerosis
University of Colorado, Boulder
Not applicableLooking for participantsNCT06676618
What this trial is testing

Effect of Multimodal Exercise Training in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Istanbul University - Cerrahpasa 40
Not applicableStudy completedNCT02247310
What this trial is testing

BETAEVAL Global - The New BETACONNECT Auto-injector : Adherence and EVALuation of Multiple Sclerosis Patients Treated With Betaferon

Who this might be right for
Multiple Sclerosis, Relapsing Remitting
Bayer 498
Not applicableStudy completedNCT05585541
What this trial is testing

Teleassessment in Ataxic Multiple Sclerosis

Who this might be right for
AtaxiaMultiple Sclerosis
Hacettepe University 30
Not applicableLooking for participantsNCT06270641
What this trial is testing

Increasing Physical Activity for Adults With Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis (MS)FatiguePhysical Inactivity
University of Washington 106
Not applicableStudy completedNCT01158183
What this trial is testing

Real-World Betaseron Health Economic Outcomes Study for Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Bayer 226
Testing effectiveness (Phase 2)Study completedNCT02804594
What this trial is testing

Oxidative Pathways in MS Fatigue

Who this might be right for
Progressive Multiple SclerosisFatigue
University of California, San Francisco 15
Early research (Phase 1)Not Yet RecruitingNCT04667013
What this trial is testing

A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of TBN

Who this might be right for
Healthy
Guangzhou Magpie Pharmaceuticals Co., Ltd. 16
Not applicableStudy completedNCT05347277
What this trial is testing

CSF Free Kappa Light Chain for The Diagnosis of Demyelinating Disorders

Who this might be right for
Multiple Sclerosis
Aga Khan University 60
Not applicableActive Not RecruitingNCT07456475
What this trial is testing

Metaverse Applications in Clinical Neurorehabiliation: Device Feasibility

Who this might be right for
Neurological DisorderMultiple SclerosisParkinson Disease+2 more
Istituto per la Ricerca e l'Innovazione Biomedica 25
Not applicableStudy completedNCT01195857
What this trial is testing

Assessment of Subject Use of the Rebiject II Injection Device According to Nurse Examination of Subject Accuracy in 10 Steps as a Dummy Demonstration

Who this might be right for
Multiple Sclerosis
Merck KGaA, Darmstadt, Germany 100
Not applicableUnknownNCT04681586
What this trial is testing

Bright Light Therapy as Possible Treatment Option for MS-Fatigue

Who this might be right for
Multiple SclerosisFatigue
Medical University of Vienna 36
Not applicableStudy completedNCT03121105
What this trial is testing

Pathologic-MRI Findings in Atypical IIDD

Who this might be right for
Idiopathic Inflammatory Demyelinating Disorders of the Central Nervous System
University Hospital, Montpellier 25
Not applicableStudy completedNCT05236777
What this trial is testing

TOPIK Study: A Study to Report Progressive Multifocal Leukoencephalopathy and Other Serious Opportunistic Infections in Natalizumab Treated Participants

Who this might be right for
Multiple Sclerosis
Biogen 675
Not applicableStudy completedNCT05299151
What this trial is testing

Gait Analysis in Multiple Sclerosis Patients

Who this might be right for
Multiple Sclerosis3D Gait AnalysisVestibular Rehabilitation
Istanbul Kültür University 22
Not applicableStudy completedNCT00819000
What this trial is testing

Therapy Optimization in Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
Teva Neuroscience, Inc. 2,878
Next Page